American Journal of Ophthalmology
Volume 142, Issue 6 , Pages 931-937.e1 , December 2006

Risk Factors For Posterior Vitreous Detachment: A Case-Control Study

  • Jean Y. Chuo, MD

      Affiliations

    • Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada
    • Corresponding Author InformationInquiries to Jean Y. Chuo, MD, Eye Care Centre, 2550 Willow St.,Vancouver, B.C. Canada, V5Z 3N9
    • ,
  • Tracy Y.Y. Lee, MD

      Affiliations

    • Discipline of Family Medicine, Faculty of Medicine, Memorial University of Newfoundland, Health Sciences Centre, St John’s, Newfoundland, Canada
    • ,
  • Hussein Hollands, MD, MSc (Epid)

      Affiliations

    • Department of Ophthalmology, Queen’s University, Kingston, Ontario, Canada
    • ,
  • Andrew H. Morris, FRCOphth

      Affiliations

    • Royal Bournemouth Hospital Eye Unit, Dorset, United Kingdom
    • ,
  • Romina C. Reyes, MD, MSc (Epid)

      Affiliations

    • Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
    • ,
  • Jonathan D. Rossiter, MRCOphth

      Affiliations

    • Royal Bournemouth Hospital Eye Unit, Dorset, United Kingdom
    • ,
  • Sarah P. Meredith, MRCOphth

      Affiliations

    • Royal Bournemouth Hospital Eye Unit, Dorset, United Kingdom
    • ,
  • David A.L. Maberley, MD, FRCSC, MSc (Epid)

      Affiliations

    • Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada

,Accepted 1 August 2006.

References 

  1. Schepens C. In: Retinal detachment and allied diseases. Philadelphia, Pennsylvania: WB Saunders Co; 1983;p. 37–67
  2. Chaine G, Sebag J, Coscas G. The induction of retinal detachment. Trans Ophthalmol Soc UK. 1983;103:480–485
  3. Foulds WS. Is your vitreous really necessary? (The role of the vitreous in the eye with particular reference to retinal attachment, detachment and the mode of action of vitreous substitutes). Eye. 1987;1:641–664
  4. Gaudric A, Haouchine B, Massin P, et al. Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol. 1999;117:744–751
  5. Diamond JP. When are simple flashes and floaters ocular emergencies?. Eye. 1992;6:102–104
  6. Hikichi T, Trempe C. Relationship between floaters, light flashes, or both, and complications of posterior vitreous detachment. Am J Ophthalmol. 1994;117:593–598
  7. Boldrey E. Risk of retinal tears in patients with vitreous floaters. Am J Ophthalmol. 1983;96:783–787
  8. Yonemoto J, Ideta H, Sasaki K, et al. The age of onset of posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol. 1994;232:67–70
  9. Foos RY, Wheeler NC. Vitreoretinal juncture (Synchysis senilis and posterior vitreous detachment). Ophthalmology. 1982;89:1502–1512
  10. Jaffe N. Complications of acute posterior vitreous detachment. Arch Ophthalmol. 1968;79:568–571
  11. Kanski J. Complications of acute posterior vitreous detachment. Am J Ophthalmol. 1975;80:44–46
  12. Novak M, Welch R. Complications of acute symptomatic posterior vitreous detachment. Am J Ophthalmol. 1984;97:308–314
  13. Morita H, Funata M, Tokoro T. A clinical study of the development of posterior vitreous detachment in high myopia. Retina. 1995;15:117–124
  14. Hikichi T, Hirokawa H, Kado M, et al. Comparison of the prevalence of posterior vitreous detachment in Whites and Japanese. Ophthalmic Surg. 1995;26:39–43
  15. Hikichi T, Akiba J, Trempe C. Prevalence of posterior vitreous detachment in retinitis pigmentosa. Ophthalmic Surg. 1995;26:34–37
  16. Ajani UA, Willett WC, Seddon JM Eye Disease Case-Control Study Group. Reproducibility of a food frequency questionnaire for use in ocular research. Invest Ophthalmol Vis Sci. 1994;35:2725–2733
  17. Sebag J. In: The Vitreous. New York, New York: Springer-Verlag; 1989;p. 73–95
  18. Evans JR, Schwartz SD, McHugh JD, et al. Systemic risk factors for idiopathic macular holes: a Case-Control Study. Eye. 1998;12:256–259
  19. The Eye Disease Case-Control Study Group. Risk factors for idiopathic macular holes. Am J Ophthalmol. 1994;118:754–761
  20. Kang HK, Chang AA, Beaumont PE. The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Experiment Ophthalmol. 2000;28:298–308
  21. Lewis ML, Cohen SM, Smiddy WE, Gass JD. Bilaterality of idiopathic macular holes. Graefes Arch Clin Exp Ophthalmol. 1996;234:241–245
  22. Azzolini C, Patelli F, Brancato R. Correlation between optical coherence tomography data and biomicroscopic interpretation of idiopathic macular hole. Am J Ophthalmol. 2001;132:348–355
  23. Schumann RG, Schaumberger MM, Rohleder M, et al. Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases. Am J Ophthalmol. 2006;141:1112–1119
  24. Smith TJ. Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts (Similar effects of glucocorticoid and thyroid hormones). J Clin Invest. 1984;74:2157–2163
  25. Smith TJ, Murata Y, Horwitz AL, et al. Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro. J Clin Invest. 1982;70:1066–1073
  26. Likar LJ, Likar IN, Robinson RW. Levels of acid mucopolysaccharides of the bovine aorta at different stages of the sexual cycle. J Atheroscler Res. 1965;5:388–396
  27. Sirek OV, Sirek A, Fikar K. The effect of sex hormones on glycosaminoglycan content of canine aorta and coronary arteries. Atherosclerosis. 1977;27:227–233
  28. Larsen G. The hyaluronic acid in the rabbit vitreous body; variations following hormonal treatment. AMA Arch Ophthalmol. 1958;60:815–825
  29. Worzala K, Hiller R, Sperduto R, et al. Postmenopausal estrogen use, type of menopause, and lens opacities. Arch Intern Med. 2001;161:1448–1454
  30. Smith W, Mitchell P, Wang J. Gender, estrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1997;25:S13–S15
  31. Allgood VE, Powell-Oliver FE, Cidlowski JA. Vitamin B6 influences glucocorticoid receptor-dependent gene expression. J Biol Chem. 1990;265:12424–12433
  32. Hayashi H, Wada H, Yoshimura T, et al. Recent topics in pyridoxal 5′-phosphate enzyme studies. Annu Rev Biochem. 1990;59:87–110
  33. Leklem J. Vitamin B6. In:  Machlin L editors. Handbook of Vitamins. New York: Marcel Dekker; 1991;p. 341–392
  34. Buffoni F. Histaminase and related amine oxidases. Pharmacol Rev. 1966;18:1163–1199
  35. Chandra RK, Sudhakaran L. Vitamin B6 modulation of immune responses and infection. In: Vitamin B6: Its role in health and disease. New York: Alan R. Liss; 1985;p. 163–175
  36. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet. 1985;19:209–252
  37. Nishigori H, Toft D. Chemical modification of the avian progesterone receptor by pyridoxal 5′-phosphate. J Biol Chem. 1979;254:9155–9161
  38. Muldoon TG, Cidlowski JA. Specific modification of rat uterine estrogen receptor by pyridoxal 5′-phosphate. J Biol Chem. 1980;255:3100–3107
  39. Hiipakka RA, Liao S. Effect of pyridoxal phosphate on the androgen receptor from rat prostate: inhibition of receptor aggregation and receptor binding to nuclei and to DNA-cellulose. J Steroid Biochem. 1980;13:841–846
  40. Tully DB, Allgood VE, Cidlowski JA. Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB J. 1994;8:343–349
  41. Davis BA, Cowing BE. Pyridoxal supplementation reduces cell proliferation and DNA synthesis in estrogen-dependent and -independent mammary carcinoma cell lines. Nutr Cancer. 2000;38:281–286
  42. Goodman JE, Lavigne JA, Wu K, et al. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis. 2001;22:1661–1665
  43. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76:678–687

PII: S0002-9394(06)00913-5

doi: 10.1016/j.ajo.2006.08.002

American Journal of Ophthalmology
Volume 142, Issue 6 , Pages 931-937.e1 , December 2006

Article Tools